Justin C. Boysen

1.3k total citations
24 papers, 681 citations indexed

About

Justin C. Boysen is a scholar working on Genetics, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Justin C. Boysen has authored 24 papers receiving a total of 681 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Genetics, 15 papers in Immunology and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Justin C. Boysen's work include Chronic Lymphocytic Leukemia Research (19 papers), Phagocytosis and Immune Regulation (10 papers) and Lymphoma Diagnosis and Treatment (6 papers). Justin C. Boysen is often cited by papers focused on Chronic Lymphocytic Leukemia Research (19 papers), Phagocytosis and Immune Regulation (10 papers) and Lymphoma Diagnosis and Treatment (6 papers). Justin C. Boysen collaborates with scholars based in United States, China and Netherlands. Justin C. Boysen's co-authors include Neil E. Kay, Tait D. Shanafelt, Susan M. Schwager, Asish K. Ghosh, Diane F. Jelinek, Charla Secreto, Timothy G. Call, Wei Ding, Clive S. Zent and Curtis A. Hanson and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Cancer Research.

In The Last Decade

Justin C. Boysen

23 papers receiving 676 citations

Peers

Justin C. Boysen

GENET

IMMUN

PFM

ONCOL

Daniela Gottardi Italy

Floris Dammeijer Netherlands

Shuhua Cheng United States

Larry Mansouri Sweden

Maria Ciccone Italy

Takashi Akasaka Japan

Michael J. Eckart Germany

Daniel Santos United States

Claudia Fazi Italy

Eva Maria Murga Penas Germany

Daniela Gottardi Italy

Justin C. Boysen

605 ×1.5

GENET

405 ×1.2

IMMUN

379 ×1.5

PFM

353 ×1.6

193 ×1.6

ONCOL

Citations per year, relative to Justin C. Boysen Justin C. Boysen (= 1×) peers Daniela Gottardi

Countries citing papers authored by Justin C. Boysen

Since Specialization

Citations

This map shows the geographic impact of Justin C. Boysen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Justin C. Boysen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Justin C. Boysen more than expected).

Fields of papers citing papers by Justin C. Boysen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Justin C. Boysen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Justin C. Boysen. The network helps show where Justin C. Boysen may publish in the future.

Co-authorship network of co-authors of Justin C. Boysen

This figure shows the co-authorship network connecting the top 25 collaborators of Justin C. Boysen. A scholar is included among the top collaborators of Justin C. Boysen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Justin C. Boysen. Justin C. Boysen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mangaonkar, Abhishek A., Terra L. Lasho, Justin C. Boysen, et al.. (2023). Cellular Interactions within Clonal Dendritic Cell Aggregates Drive Immune Tolerance in Chronic Myelomonocytic Leukemia Bone Marrow Microenvironment. Blood. 142(Supplement 1). 4077–4077.

Wang, Zhiquan, Huihuang Yan, Justin C. Boysen, et al.. (2022). B cell receptor signaling drives APOBEC3 expression via direct enhancer regulation in chronic lymphocytic leukemia B cells. Blood Cancer Journal. 12(7). 99–99. 4 indexed citations

Maiti, Guru Prasad, Sutapa Sinha, Hasan Mahmud, et al.. (2021). SIRT3 overexpression and epigenetic silencing of catalase regulate ROS accumulation in CLL cells activating AXL signaling axis. Blood Cancer Journal. 11(5). 93–93. 23 indexed citations

Sakemura, Reona, Nan Yang, Michelle J. Cox, et al.. (2019). Axl-RTK Inhibition Modulates T Cell Functions and Synergizes with Chimeric Antigen Receptor T Cell Therapy in B Cell Malignancies. Biology of Blood and Marrow Transplantation. 25(3). S165–S165. 2 indexed citations

Cox, Michelle J., Reona Sakemura, Justin C. Boysen, et al.. (2019). Circulating Extracellular Vesicles Induce Chimeric Antigen Receptor T Cell Dysfunction in Chronic Lymphocytic Leukemia (CLL). Blood. 134(Supplement_1). 679–679. 2 indexed citations

Sinha, Sutapa, Justin C. Boysen, Kari G. Chaffee, et al.. (2018). Chronic lymphocytic leukemia cells from ibrutinib treated patients are sensitive to Axl receptor tyrosine kinase inhibitor therapy. Oncotarget. 9(98). 37173–37184. 9 indexed citations

Sakemura, Reona, Nan Yang, Michelle J. Cox, et al.. (2018). Axl-RTK Inhibition Modulates T Cell Functions and Synergizes with Chimeric Antigen Receptor T Cell Therapy in B Cell Malignancies. Blood. 132(Supplement 1). 728–728. 1 indexed citations

Hampel, Paul J., Melissa C. Larson, Brian Kabat, et al.. (2018). Autoimmune cytopenias in patients with chronic lymphocytic leukaemia treated with ibrutinib in routine clinical practice at an academic medical centre. British Journal of Haematology. 183(3). 421–427. 38 indexed citations

Lucien, Fabrice, Tyler T. Cooper, Yohan Kim, et al.. (2018). Analytical Considerations in Nanoscale Flow Cytometry of Extracellular Vesicles to Achieve Data Linearity. Thrombosis and Haemostasis. 118(9). 1612–1624. 38 indexed citations

10.

Larsen, Jeremy T., Tait D. Shanafelt, José F. Leis, et al.. (2017). Akt inhibitor MK‐2206 in combination with bendamustine and rituximab in relapsed or refractory chronic lymphocytic leukemia: Results from the N1087 alliance study. American Journal of Hematology. 92(8). 759–763. 18 indexed citations

11.

Boysen, Justin C., Guru Prasad Maiti, Sutapa Sinha, et al.. (2016). Dynamics of microvesicle generation in B-cell chronic lymphocytic leukemia: implication in disease progression. Leukemia. 31(2). 350–360. 29 indexed citations

12.

Adams, Jeramie J., et al.. (2016). Selective Asphaltene Precipitation from Hydroconverted Bottoms. Energy & Fuels. 30(11). 9658–9670. 1 indexed citations

13.

Sinha, Sutapa, Justin C. Boysen, Charla Secreto, et al.. (2015). Targeted Axl Inhibition Primes Chronic Lymphocytic Leukemia B Cells to Apoptosis and Shows Synergistic/Additive Effects in Combination with BTK Inhibitors. Clinical Cancer Research. 21(9). 2115–2126. 59 indexed citations

14.

Sinha, Sutapa, Justin C. Boysen, Charla Secreto, et al.. (2014). Targeted Inhibition of Axl Primes Chronic Lymphocytic Leukemia B-Cells for Apoptosis: Synergistic/Additive Effects in Combination with Bruton Tyrosine Kinase Inhibitors. Blood. 124(21). 1946–1946. 2 indexed citations

15.

Ghosh, Asish K., Justin C. Boysen, Tammy Price-Troska, et al.. (2011). Axl Receptor Tyrosine Kinase Signaling Pathway and the p53 Tumor Suppressor Protein Exist In A Novel Regulatory Loop In B-Cell Chronic Lymphocytic Leukemia Cells. Blood. 118(21). 799–799. 2 indexed citations

16.

Ghosh, Asish K., Charla Secreto, Justin C. Boysen, et al.. (2010). The novel receptor tyrosine kinase Axl is constitutively active in B-cell chronic lymphocytic leukemia and acts as a docking site of nonreceptor kinases: implications for therapy. Blood. 117(6). 1928–1937. 88 indexed citations

17.

Ghosh, Asish K., Charla Secreto, Justin C. Boysen, et al.. (2010). A Novel Receptor Tyrosine Kinase Axl is Constitutively Active in B-Cell Chronic Lymphocytic Leukemia and Acts as a Docking Site of Non-Receptor Kinases: Implications for Therapy. Blood. 116(21). 54–54. 2 indexed citations

18.

Ding, Wei, Grzegorz S. Nowakowski, Traci R. Knox, et al.. (2009). Bi‐directional activation between mesenchymal stem cells and CLL B‐cells: implication for CLL disease progression. British Journal of Haematology. 147(4). 471–483. 68 indexed citations

19.

Shanafelt, Tait D., Neil E. Kay, Kari G. Rabe, et al.. (2009). Brief Report: Natural History of Individuals With Clinically Recognized Monoclonal B-Cell Lymphocytosis Compared With Patients With Rai 0 Chronic Lymphocytic Leukemia. Journal of Clinical Oncology. 27(24). 3959–3963. 100 indexed citations

20.

Shanafelt, Tait D., Neil E. Kay, G. Douglas Jenkins, et al.. (2008). B-cell count and survival: differentiating chronic lymphocytic leukemia from monoclonal B-cell lymphocytosis based on clinical outcome. Blood. 113(18). 4188–4196. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact